Original language | English |
---|---|
Journal | International Journal of Cardiology |
Volume | 268 |
Pages (from-to) | 113-119 |
ISSN | 0167-5273 |
DOIs | |
Publication status | Published - 1 Oct 2018 |
Keywords
- Non-valvular atrial fibrillation
- Direct oral anticoagulant
- Stroke
- Major bleeding
- Propensity-matched comparison
Fingerprint
Dive into the research topics of 'Comparative effectiveness and safety of apixaban, dabigatran, and rivaroxaban in patients with non-valvular atrial fibrillation'. Together they form a unique fingerprint.Cite this
Andersson, N. W., Svanstrom, H., Lund, M., Pasternak, B., & Melbye, M. (2018). Comparative effectiveness and safety of apixaban, dabigatran, and rivaroxaban in patients with non-valvular atrial fibrillation. International Journal of Cardiology, 268, 113-119. https://doi.org/10.1016/j.ijcard.2018.03.047